hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial–mesenchymal transition through inhibition of Slug transcription-Reference-Cited by-同舟云学术

hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial–mesenchymal transition through inhibition of Slug transcription

Published:2014-01-08 Issue:7 Volume:35 Page:1481-1490
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Wen Fan-Chih,Chang Tsai-Wang,Tseng Yau-Lin,Lee Janq-Chang,Chang Ming-Chung

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/35/7/1481/14133359/bgu009.pdf

Reference40 articles.

1. Living on a break: cellular senescence as a DNA-damage response;d’Adda di Fagagna;Nat. Rev. Cancer,(2008)

2. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths;Smit;Aging (Albany. NY).,(2010)

3. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs;Chang;Nat. Cell Biol.,(2011)

4. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo;Liu;Proc. Natl Acad. Sci. USA,(2009)

5. Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer;Arima;J. Biol. Chem.,(2012)

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR;Seminars in Cancer Biology;2023-12

2. Resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1–DYRK1A–EGFR axis;Food & Function;2023

3. DNA binding by the Rad9A subunit of the Rad9-Rad1-Hus1 complex;PLOS ONE;2022-08-08

4. SIRT1 upregulation promotes epithelial-mesenchymal transition by inducing senescence escape in endometriosis;Scientific Reports;2022-07-19

5. DOC2B is a negative regulator of Wnt/β-catenin signaling pathway in cervical cancer;Pharmacological Research;2022-06